ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1β

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Robaszkiewicz, Agnieszka ^a,b   Qu, Chao ^c   Wisnik, Ewelina ^b   Ploszaj, Tomasz ^d   Mirsaidi, Ali ^a   Kunze, Friedrich A ^a   Richards, Peter J ^a   Cinelli, Paolo ^e   Mbalaviele, Gabriel ^c   Hottiger, Michael O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF LODZ   (Poland)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN BINDING; TRANSCRIPTION FACTOR NFAT;

ANIMAL; AUTOCRINE EFFECT; BINDING SITE; BONE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; MOUSE; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PROMOTER REGION; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; BINDING SITES; BONE AND BONES; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; DNA TOPOISOMERASES, TYPE II; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HOMEOSTASIS; INFLAMMASOMES; INTERLEUKIN-1BETA; MICE; MICE, KNOCKOUT; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PHENOTYPE; POLY (ADP-RIBOSE) POLYMERASE-1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RANK LIGAND; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84958581168     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21131     Document Type: Article

References (51)

1. Hottiger, M. O. Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics. Annu. Rev. Biochem. 84, 227-263 (2015).
2. D'Amours, D., Desnoyers, S., D'Silva, I., Poirier, G. G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342, 249-268 (1999).
3. Ji, Y., Tulin, A. V. The roles of PARP1 in gene control and cell differentiation. Curr. Opin. Genet. Dev. 20, 512-518 (2010).
4. Kraus, W. L. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr. Opin. Cell Biol. 20, 294-302 (2008).
5. Krishnakumar, R., Kraus, W. L. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39, 8-24 (2010).
6. Frizzell, K. M. et al. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J. Biol. Chem. 284, 33926-33938 (2009).
7. Luo, X., Kraus, W. L. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 26, 417-432 (2012).
8. Slattery, E., Dignam, J. D., Matsui, T., Roeder, R. G. Purification and analysis of a factor which suppresses nick-induced transcription by RNA polymerase II and its identity with poly(ADP-ribose) polymerase. J. Biol. Chem. 258, 5955-5959 (1983).
9. Kraus, W. L., Hottiger, M. O. PARP-1 and gene regulation: progress and puzzles. Mol. Aspects Med. 34, 1109-1123 (2013).
10. Erener, S., Hesse, M., Kostadinova, R., Hottiger, M. O. Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function. Mol. Endocrinol. 26, 79-86 (2012).
11. Erener, S. et al. ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation. FASEB J. 26, 2631-2638 (2012).
12. Fujiki, K. et al. PPARgamma-induced PARylation promotes local DNA demethylation by production of 5-hydroxymethylcytosine. Nat. Commun. 4, 2262 (2013).
13. Suda, T. et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357 (1999).
14. Teitelbaum, S. L. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
15. Walsh, M. C. et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24, 33-63 (2006).
16. Long, F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 13, 27-38 (2012).
17. Boyle, W. J., Simonet, W. S., Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337-342 (2003).
18. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002).
19. Hayden, M. S., West, A. P., Ghosh, S. NF-kappaB and the immune response. Oncogene 25, 6758-6780 (2006).
20. Boyce, B. F., Schwarz, E. M., Xing, L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18, 427-432 (2006).
21. Lee, S. K., Lorenzo, J. Cytokines regulating osteoclast formation and function. Curr. Opin. Rheumatol. 18, 411-418 (2006).
22. Robaszkiewicz, A. et al. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Radic. Biol. Med. 53, 1552-1564 (2012).
23. Robaszkiewicz, A. et al. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway. Free Radic. Biol. Med. 76, 69-79 (2014).
24. Beranger, G. E., Momier, D., Rochet, N., Carle, G. F., Scimeca, J. C. Poly(adp-ribose) polymerase-1 regulates Tracp gene promoter activity during RANKL-induced osteoclastogenesis. J. Bone Miner. Res. 23, 564-571 (2008).
25. Beranger, G. E. et al. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis. J. Bone Miner. Res. 21, 1757-1769 (2006).
26. Rodriguez-Vargas, J. M. et al. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res. 22, 1181-1198 (2012).
27. Lehmann, M. et al. ARTD1-induced poly-ADP-ribose formation enhances PPARgamma ligand binding and co-factor exchange. Nucleic Acids Res. 43, 129-142 (2015).
28. Lee, Y. M., Fujikado, N., Manaka, H., Yasuda, H., Iwakura, Y. IL-1 plays an important role in the bone metabolism under physiological conditions. Int. Immunol. 22, 805-816 (2010).
29. Scianaro, R. et al. Deregulation of the IL-1beta axis in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J 12, 30 (2014).
30. Kim, J. H. et al. The mechanism of osteoclast differentiation induced by IL-1. J. Immunol. 183, 1862-1870 (2009).
31. Tolar, J., Teitelbaum, S. L., Orchard, P. J. Osteopetrosis. N. Engl. J. Med. 351, 2839-2849 (2004).
32. Rachner, T. D., Khosla, S., Hofbauer, L. C. Osteoporosis: now and the future. Lancet 377, 1276-1287 (2011).
33. Scott, D. L., Wolfe, F., Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094-1108 (2010).
34. Mundy, G. R., Raisz, L. G., Cooper, R. A., Schechter, G. P., Salmon, S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N. Engl. J. Med. 291, 1041-1046 (1974).
35. Yoneda, T. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur. J. Cancer 34, 240-245 (1998).
36. Nicholson, G. C. et al. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin. Sci. 99, 133-140 (2000).
37. Garlanda, C., Dinarello, C. A., Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003-1018 (2013).
38. Dewhirst, F. E., Stashenko, P. P., Mole, J. E., Tsurumachi, T. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. J. Immunol. 135, 2562-2568 (1985).
39. Souza, P. P., Lerner, U. H. The role of cytokines in inflammatory bone loss. Immunol. Invest. 42, 555-622 (2013).
40. Yao, Z., Xing, L., Qin, C., Schwarz, E. M., Boyce, B. F. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism. J. Biol. Chem. 283, 9917-9924 (2008).
41. Wei, S., Kitaura, H., Zhou, P., Ross, F. P., Teitelbaum, S. L. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115, 282-290 (2005).
42. Polzer, K. et al. Interleukin-1 is essential for systemic inflammatory bone loss. Ann. Rheum. Dis. 69, 284-290 (2010).
43. Zwerina, J. et al. TNF-induced structural joint damage is mediated by IL-1. Proc. Natl. Acad. Sci. USA 104, 11742-11747 (2007).
44. Krishnakumar, R., Kraus, W. L. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol. Cell 39, 736-749 (2010).
45. Lukens, J. R. et al. Critical role for inflammasome-independent IL-1beta production in osteomyelitis. Proc. Natl. Acad. Sci. USA 111, 1066-1071 (2014).
46. Jimi, E. et al. Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J. Biol. Chem. 273, 8799-8805 (1998).
47. Bonar, S. L. et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS ONE 7, e35979 (2012).
48. Qu, C. et al. NLRP3 mediates osteolysis through inflammation-dependent and-independent mechanisms. FASEB J. 29, 1269-1279 (2015).
49. Wang, Z. Q. et al. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9, 509-520 (1995).
50. Saccani, S., Pantano, S., Natoli, G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 3, 69-75 (2002).
51. Mirsaidi, A. et al. Therapeutic potential of adipose-derived stromal cells in age-related osteoporosis. Biomaterials 35, 7326-7335 (2014).